Bio Preventive Medicine Corp. announced on October 11, 2023 that its IVD product, DNlite-DKD uPTM-FetA ELISA Kit (aka DNlite-IVD103), has received marketing approval from Thai FDA. This is the third marketing approval following authorization from EU and Malaysia. DNlite-IVD103 is used as an aid in assessing the prognosis of kidney function in type 2 diabetes patients. The new and improved DNlite-IVD103 kit has a shorter operating time and a streamlined transportation conditions compared to previous generation.
Currently we are looking for distribution partners in Thailand. Please contact email@example.com if interested.